Can "small three positives" become negative after receiving the hepatitis B vaccine?
Generally, receiving the hepatitis B vaccine does not lead to seronegative conversion in individuals with "minor three positive" status.
"Minor three positive" refers to a condition in which, among the three indicators—hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B e-antigen (HBeAg)—the first two are positive while the last is negative. The hepatitis B vaccine is not a treatment for hepatitis B infection. While vaccination effectively prevents hepatitis B virus (HBV) infection, it cannot eliminate the virus or induce seronegative conversion in individuals already infected.
For patients already infected with HBV, specific antiviral treatment is required. Current treatment strategies primarily include antiviral therapy and immune modulation therapy. Antiviral therapy effectively suppresses viral replication and reduces viral load, thereby controlling disease progression and minimizing liver damage. Immune modulation therapy enhances the body's immune response to promote viral clearance.
Hepatitis B virus infection is a chronic viral hepatitis that requires long-term, consistent treatment; patients should not discontinue treatment prematurely. Additionally, because HBV is infectious, individuals should maintain good personal hygiene and take appropriate preventive measures to avoid transmitting the virus to others.